AAPG Key Statistics, Chart & Performance
The current stock price of AAPG is 26.2 USD. In the past month the price decreased by -10.61%.
AAPG Technical Analysis
AAPG Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AAPG. AAPG may be in some trouble as it scores bad on both profitability and health.
AAPG Financial Highlights
Over the last trailing twelve months AAPG reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS decreased by -184.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.05% | ||
| ROE | -174.06% | ||
| Debt/Equity | 1.99 |
AAPG Forecast & Estimates
13 analysts have analysed AAPG and the average price target is 35.58 USD. This implies a price increase of 35.78% is expected in the next year compared to the current price of 26.2.
For the next year, analysts expect an EPS growth of -185.96% and a revenue growth -42.1% for AAPG
AAPG Ownership
About AAPG
Company Profile
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Company Info
ASCENTAGE PHARMA GR-ADR
68 Xinqing Road, Suzhou Industrial Park
Suzhou JIANGSU CN
Employees: 605
ASCENTAGE PHARMA GR-ADR / AAPG FAQ
What does AAPG do?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
What is the stock price of ASCENTAGE PHARMA GR-ADR today?
The current stock price of AAPG is 26.2 USD. The price decreased by -0.72% in the last trading session.
What is the dividend status of ASCENTAGE PHARMA GR-ADR?
AAPG does not pay a dividend.
How is the ChartMill rating for ASCENTAGE PHARMA GR-ADR?
AAPG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for ASCENTAGE PHARMA GR-ADR?
ASCENTAGE PHARMA GR-ADR (AAPG) currently has 605 employees.
Can you provide the ownership details for AAPG stock?
You can find the ownership structure of ASCENTAGE PHARMA GR-ADR (AAPG) on the Ownership tab.
What is the outstanding short interest for ASCENTAGE PHARMA GR-ADR?
The outstanding short interest for ASCENTAGE PHARMA GR-ADR (AAPG) is 0% of its float.